During last week’s American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, bluebird bio Inc (NASDAQ:BLUE) provided clinical updates on …
After Synergy Pharmaceuticals Inc (NASDAQ:SGYP) yielded positive Phase 3 top-line data in the first of two pivotal Phase 3 trials in adults with …
Heat Biologics Inc (NASDAQ:HTBX) shares fell over 65% this month, after the firm’s Phase II data read-out from its HS-410 bladder cancer trial …
Roth Capital analyst Philip Shen is out with a research report on Enphase Energy Inc (NASDAQ:ENPH) after recently hosting meetings with the firm’s …
Roth Capital analyst Mark Breidenbach is out today with a favorable report on shares of Global Blood Therapeutics Inc (NASDAQ:GBT), after the company provided updated …
The biotech-verse is in full upheaval mode as Heat Biologics Inc (NASDAQ:HTBX) shares nosedive following disheartening Phase II results in bladder cancer and …
Roth Capital analyst William Gibson provides insight on xG Technology Inc (NASDAQ:XGTI) following the company’s recent third-quarter print and amid a forthcoming acquisition …
Last week, Glu Mobile Inc. (NASDAQ:GLUU) unveiled “Design Home,” a gaming platform that “brings the best of the design world to [gamers’] fingertips …
Yesterday, Palatin Technologies, Inc. (NYSEMKT:PTN) announced its fiscal first quarter results for 2017, with Roth Capital analyst Joseph Pantginis determining that “all eyes” …
In a research report issued today, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on shares of Sophiris Bio Inc (NASDAQ:SPHS) with …
